(Alliance News) - Novacyt SA on Tuesday named Steve Gibson as its new chief financial officer, with immediate effect.

Novacyt is an Eastleigh-based biotechnology group focused on clinical diagnostics.

Gibson joined Novacyt in 2017 and has served as group finance director since 2020.

In November, Novacyt said Chief Executive David Allmond was stepping down immediately. In his place, CFO James McCarthy assumed the role of acting CEO. At the time, Gibson took a substantial part of CFO responsibilities on.

Non-Executive Chair James Wakefield said: "We are delighted to welcome Steve as our CFO. He has impressed us with his financial and operational expertise and was instrumental in the acquisition of Yourgene Health PLC as well as delivering the strategic changes to the company over the last two years. The board looks forward to working with him as we continue to execute our growth strategy."

Novacyt completed the acquisition of Yourgene, a Manchester, England-based molecular diagnostics group, for about GBP17 million in September.

Novacyt shares fell 0.4% to 61.25 pence each in London on Tuesday morning.

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved